Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Colorectal Cancer

Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Doctors Hospital
1960
mi
from 91732
Columbus, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Doctors Hospital
1960
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Summa Western Reserve (Summa Health System)
2040
mi
from 91732
Cuyahoga Falls, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Summa Western Reserve (Summa Health System)
2040
mi
from 91732
Cuyahoga Falls, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Miami Valley Hospital
1897
mi
from 91732
Dayton, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Miami Valley Hospital
1897
mi
from 91732
Dayton, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Good Samaritan Hospital - Dayton
1897
mi
from 91732
Dayton, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Good Samaritan Hospital - Dayton
1897
mi
from 91732
Dayton, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Kettering Medical Center
1897
mi
from 91732
Dayton, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Kettering Medical Center
1897
mi
from 91732
Dayton, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Wright-Patterson Medical Center
1904
mi
from 91732
Dayton, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Wright-Patterson Medical Center
1904
mi
from 91732
Dayton, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Grady Memorial Hospital
1957
mi
from 91732
Delaware, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Grady Memorial Hospital
1957
mi
from 91732
Delaware, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Mercy Fairfield
1877
mi
from 91732
Fairfield, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Mercy Fairfield
1877
mi
from 91732
Fairfield, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Blanchard Valley Health System
1929
mi
from 91732
Findlay, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Blanchard Valley Health System
1929
mi
from 91732
Findlay, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Wayne Healthcare
1874
mi
from 91732
Greenville, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Wayne Healthcare
1874
mi
from 91732
Greenville, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Fairfield Medical Center
1981
mi
from 91732
Lancaster, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Fairfield Medical Center
1981
mi
from 91732
Lancaster, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
St. Rita's Medical Center
1905
mi
from 91732
Lima, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
St. Rita's Medical Center
1905
mi
from 91732
Lima, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Marietta Memorial Hospital
2042
mi
from 91732
Marietta, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Marietta Memorial Hospital
2042
mi
from 91732
Marietta, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Marion General Hospital
1954
mi
from 91732
Marion, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Marion General Hospital
1954
mi
from 91732
Marion, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
St. Luke's Hospital (ProMedica)
1931
mi
from 91732
Maumee, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
St. Luke's Hospital (ProMedica)
1931
mi
from 91732
Maumee, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Hillcrest Hospital
2045
mi
from 91732
Mayfield Heights, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Hillcrest Hospital
2045
mi
from 91732
Mayfield Heights, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Atrium Medical Center
1886
mi
from 91732
Middletown, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Atrium Medical Center
1886
mi
from 91732
Middletown, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Knox Community Hospital
1988
mi
from 91732
Mount Vernon, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Knox Community Hospital
1988
mi
from 91732
Mount Vernon, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Licking Memorial Hospital
1992
mi
from 91732
Newark, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Licking Memorial Hospital
1992
mi
from 91732
Newark, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Southern Ohio Medical Center
1961
mi
from 91732
Portsmouth, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Southern Ohio Medical Center
1961
mi
from 91732
Portsmouth, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Robinson Memorial (Summa Health System)
2054
mi
from 91732
Ravenna, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Robinson Memorial (Summa Health System)
2054
mi
from 91732
Ravenna, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Springfield Regional Medical Center
1920
mi
from 91732
Springfield, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Springfield Regional Medical Center
1920
mi
from 91732
Springfield, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Flower Hospital (ProMedica Health System)
1929
mi
from 91732
Sylvania, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Flower Hospital (ProMedica Health System)
1929
mi
from 91732
Sylvania, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Toledo Hospital (Promedica Health System)
1933
mi
from 91732
Toledo, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Toledo Hospital (Promedica Health System)
1933
mi
from 91732
Toledo, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Upper Valley Medical Center
1897
mi
from 91732
Troy, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Upper Valley Medical Center
1897
mi
from 91732
Troy, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
South Pointe Hospital
2040
mi
from 91732
Warrensville Heights, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
South Pointe Hospital
2040
mi
from 91732
Warrensville Heights, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Mount Carmel St. Ann's Hospital
1963
mi
from 91732
Westerville, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Mount Carmel St. Ann's Hospital
1963
mi
from 91732
Westerville, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Genesis Cancer Care Center
2013
mi
from 91732
Zanesville, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Genesis Cancer Care Center
2013
mi
from 91732
Zanesville, OH
Click here to add this to my saved trials
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated:  12/31/1969
Toledo Clinic Cancer Center
1929
mi
from 91732
Maumee, OH
Ohio Colorectal Cancer Prevention Initiative
Ohio Colorectal Cancer Prevention Initiative: Universal Screening for Lynch Syndrome
Status: Enrolling
Updated: 12/31/1969
Toledo Clinic Cancer Center
1929
mi
from 91732
Maumee, OH
Click here to add this to my saved trials
Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors
A Prospective Evaluation of the Effect of Curcumin on Dose-limiting Toxicity and Pharmacokinetics of Irinotecan in Colorectal Cancer Patients
Status: Enrolling
Updated:  12/31/1969
IU Simon Cancer Center
1793
mi
from 91732
Indianapolis, IN
Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors
A Prospective Evaluation of the Effect of Curcumin on Dose-limiting Toxicity and Pharmacokinetics of Irinotecan in Colorectal Cancer Patients
Status: Enrolling
Updated: 12/31/1969
IU Simon Cancer Center
1793
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors
A Prospective Evaluation of the Effect of Curcumin on Dose-limiting Toxicity and Pharmacokinetics of Irinotecan in Colorectal Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Univ. of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center
2189
mi
from 91732
Chapel Hill, NC
Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors
A Prospective Evaluation of the Effect of Curcumin on Dose-limiting Toxicity and Pharmacokinetics of Irinotecan in Colorectal Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Univ. of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center
2189
mi
from 91732
Chapel Hill, NC
Click here to add this to my saved trials
A Phase I Study of Nilontinib and Cetuximab in Patients With Solid Tumors
A Phase I Study of the BCR-ABL Tyrosine Kinase Inhibitor Nilontinib and Cetuximab in Patients With Solid Tumors That Can be Treated With Cetuximab
Status: Enrolling
Updated:  12/31/1969
Georgetown Lombardi Comprehensive Cancer Center
2281
mi
from 91732
Washington,
A Phase I Study of Nilontinib and Cetuximab in Patients With Solid Tumors
A Phase I Study of the BCR-ABL Tyrosine Kinase Inhibitor Nilontinib and Cetuximab in Patients With Solid Tumors That Can be Treated With Cetuximab
Status: Enrolling
Updated: 12/31/1969
Georgetown Lombardi Comprehensive Cancer Center
2281
mi
from 91732
Washington,
Click here to add this to my saved trials
Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer
Phase II Trial Of Neoadjuvant Bevacizumab With Modified FOLFOX7 In Patients With Stage II And III Rectal Cancer
Status: Enrolling
Updated:  12/31/1969
U.S.C./Norris Comprehensive Cancer Center
11
mi
from 91732
Los Angeles, CA
Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer
Phase II Trial Of Neoadjuvant Bevacizumab With Modified FOLFOX7 In Patients With Stage II And III Rectal Cancer
Status: Enrolling
Updated: 12/31/1969
U.S.C./Norris Comprehensive Cancer Center
11
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  12/31/1969
City of Hope
5
mi
from 91732
Duarte, CA
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 12/31/1969
City of Hope
5
mi
from 91732
Duarte, CA
Click here to add this to my saved trials
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  12/31/1969
Florida Cancer Center
2151
mi
from 91732
Sarasota, FL
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 12/31/1969
Florida Cancer Center
2151
mi
from 91732
Sarasota, FL
Click here to add this to my saved trials
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  12/31/1969
Henry Ford Health System
1965
mi
from 91732
Detroit, MI
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 12/31/1969
Henry Ford Health System
1965
mi
from 91732
Detroit, MI
Click here to add this to my saved trials
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  12/31/1969
Fox Chase Cancer Center
2379
mi
from 91732
Philadelphia, PA
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 12/31/1969
Fox Chase Cancer Center
2379
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  12/31/1969
University of California Irvine College of Medicine
31
mi
from 91732
Irvine, CA
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 12/31/1969
University of California Irvine College of Medicine
31
mi
from 91732
Irvine, CA
Click here to add this to my saved trials
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  12/31/1969
University of California at San Diego Moores Cancer Center
105
mi
from 91732
San Diego, CA
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 12/31/1969
University of California at San Diego Moores Cancer Center
105
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  12/31/1969
Lombardi Comprehensive Cancer Center, Georgetown
2279
mi
from 91732
Washington,
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 12/31/1969
Lombardi Comprehensive Cancer Center, Georgetown
2279
mi
from 91732
Washington,
Click here to add this to my saved trials
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  12/31/1969
University Cancer and Blood Center LLC
1967
mi
from 91732
Athens, GA
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 12/31/1969
University Cancer and Blood Center LLC
1967
mi
from 91732
Athens, GA
Click here to add this to my saved trials
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital / Beth Israel Deaconess Med Ctr / Dana-Farber Cancer Institute
2577
mi
from 91732
Boston, MA
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital / Beth Israel Deaconess Med Ctr / Dana-Farber Cancer Institute
2577
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  12/31/1969
Karmanos Cancer Center
1965
mi
from 91732
Detroit, MI
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 12/31/1969
Karmanos Cancer Center
1965
mi
from 91732
Detroit, MI
Click here to add this to my saved trials
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  12/31/1969
Washington University
1568
mi
from 91732
Saint Louis, MO
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 12/31/1969
Washington University
1568
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
2434
mi
from 91732
New York, NY
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
2434
mi
from 91732
New York, NY
Click here to add this to my saved trials
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  12/31/1969
University of Texas M.D. Anderson Cancer Center
1357
mi
from 91732
Houston, TX
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  12/31/1969
University of Washington/Seattle Cancer Care Alliance
963
mi
from 91732
Seattle, WA
Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 12/31/1969
University of Washington/Seattle Cancer Care Alliance
963
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer
A Pilot Study of Active Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
2203
mi
from 91732
Durham, NC
Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer
A Pilot Study of Active Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
2203
mi
from 91732
Durham, NC
Click here to add this to my saved trials
A Trial of PledOx + FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Metastatic Colorectal Cancer
A Double Blinded Randomised Three Armed Phase II Trial of PledOx in Two Different Doses in Combination With FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Advanced Metastatic Colorectal (Stage IV) Cancer
Status: Enrolling
Updated:  12/31/1969
Center for Cancer & Blood Disorders
2275
mi
from 91732
Bethesda, MD
A Trial of PledOx + FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Metastatic Colorectal Cancer
A Double Blinded Randomised Three Armed Phase II Trial of PledOx in Two Different Doses in Combination With FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Advanced Metastatic Colorectal (Stage IV) Cancer
Status: Enrolling
Updated: 12/31/1969
Center for Cancer & Blood Disorders
2275
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
A Trial of PledOx + FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Metastatic Colorectal Cancer
A Double Blinded Randomised Three Armed Phase II Trial of PledOx in Two Different Doses in Combination With FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Advanced Metastatic Colorectal (Stage IV) Cancer
Status: Enrolling
Updated:  12/31/1969
Associates in Oncology and Hematology
1855
mi
from 91732
Chattanooga, TN
A Trial of PledOx + FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Metastatic Colorectal Cancer
A Double Blinded Randomised Three Armed Phase II Trial of PledOx in Two Different Doses in Combination With FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Advanced Metastatic Colorectal (Stage IV) Cancer
Status: Enrolling
Updated: 12/31/1969
Associates in Oncology and Hematology
1855
mi
from 91732
Chattanooga, TN
Click here to add this to my saved trials